Brachytherapy News and Research

RSS
Brachytherapy is a minimally invasive procedure that involves the use of radioactive seeds the size of rice grains. Brachytherapy, an out-patient procedure, usually takes 45 minutes to an hour to perform. Most patients can return to their normal activities within days. The success rates of prostate brachytherapy have compared favorably with success rates of radical prostatectomy and external beam radiation. In comparison studies, prostate brachytherapy has shown to have a favorable side effect profile when compared with other modalities. Clinical studies have shown that prostate brachytherapy has a cure rate of 94% for appropriately selected patients.
Innovative radiotherapy technique benefits patients with locally advanced cervical cancer

Innovative radiotherapy technique benefits patients with locally advanced cervical cancer

Medical mistrust can make African Americans to regret their choice of treatment for prostate cancer

Medical mistrust can make African Americans to regret their choice of treatment for prostate cancer

Researchers report outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer

Researchers report outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer

Combination of antibodies and internal radiation can help fight cervical cancer

Combination of antibodies and internal radiation can help fight cervical cancer

ASTRO's new guideline provides recommendations for radiation therapy to treat cervical cancer

ASTRO's new guideline provides recommendations for radiation therapy to treat cervical cancer

Study evaluates the impact of prostate cancer treatment decisions

Study evaluates the impact of prostate cancer treatment decisions

Prostate cancer patients receiving care at MultiD clinic more likely to be advised about treatment choices

Prostate cancer patients receiving care at MultiD clinic more likely to be advised about treatment choices

ASTRO and ACR release updated practice parameters for radiation therapy

ASTRO and ACR release updated practice parameters for radiation therapy

Using X-ray-nanoparticle interactions for improved radiation therapy

Using X-ray-nanoparticle interactions for improved radiation therapy

Cosmetic appearance after skin cancer therapy may differ based on treatment type

Cosmetic appearance after skin cancer therapy may differ based on treatment type

World’s first clinical guidance on anal sex after prostate cancer treatments

World’s first clinical guidance on anal sex after prostate cancer treatments

Single high dose of radiation targeted directly to tumor is safe and effective for prostate cancer

Single high dose of radiation targeted directly to tumor is safe and effective for prostate cancer

Combination of radiotherapy and anti-hormone treatment can prevent recurrence of hormone-driven breast cancer

Combination of radiotherapy and anti-hormone treatment can prevent recurrence of hormone-driven breast cancer

New technology provides clearer picture to clinicians treating gynecological cancer

New technology provides clearer picture to clinicians treating gynecological cancer

UMGCCC uses Gammapod radiotherapy to treat breast cancer patients

UMGCCC uses Gammapod radiotherapy to treat breast cancer patients

LDR brachytherapy for treating early-stage prostate cancer lacks conclusive data

LDR brachytherapy for treating early-stage prostate cancer lacks conclusive data

NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach

NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach

Patient-reported data confirms efficacy of brachytherapy alone in intermediate risk prostate cancer

Patient-reported data confirms efficacy of brachytherapy alone in intermediate risk prostate cancer

New guideline supports hypofractionated radiation therapy for men with prostate cancer

New guideline supports hypofractionated radiation therapy for men with prostate cancer

Robot could become the 'weapon' of choice for detecting and treating prostate cancer

Robot could become the 'weapon' of choice for detecting and treating prostate cancer